|
London, UK Business News
|
Home | Submit Press Release | Advertise | Submit Website
(EMAILWIRE.COM, December 12, 2015 ) The university of Washington conducted an investigative trial on the Drug Rapamycin which is used to treat patients organ rejection in humans after a transplant is also know to fight cancer. A trial involving dogs between the age of 6 and 9 was conducted on various breeds and the lifespan is being tested.
The test on mice has shown an increase in lifespan and other organisms. The lifespan of a dog is expected to increase with the administration of rapamycin in slow doses and the lifespan increased by 2-5 years.
Rapamycin is not just used to increase the lifespan but to increase the healthier part of the lifespan in dogs. Rapamycin has also been known to be effective in preventing a range of conditions in dogs from cardiovascular problems, kidney failure and dementia.
The drug may also be used on other animals including cats (and even humans) if found successful.
Also a research on animals with a faster heart rate is being studied with their link to shorter lifespan.
Admarkon
Rajeev
+918547843409
design2host@gmail.com
Source: EmailWire.Com
|
|
|
London, UK News by Region
|
|
|
Press Release Writing & Distribution
We write and distribute your press release to online major media outlets for only 199. Fast turn around.
More on
Press Release Writing & Distribution
LONDON, UK TV NEWS
|